Literature DB >> 11398138

Factors explaining the difference of total homocysteine between men and women in the European Investigation Into Cancer and Nutrition Potsdam study.

J Dierkes1, A Jeckel, A Ambrosch, S Westphal, C Luley, H Boeing.   

Abstract

Interestingly, plasma total homocysteine (tHcy) concentration is consistently higher in men than in women. This observation deserves further investigations because elevated tHcy concentrations have been shown to be independently associated with coronary, peripheral, and cerebral vascular diseases. It was the aim of the present study to define major determinants of plasma tHcy in a healthy middle-aged German population under particular consideration of the gender factor. The study population was obtained from an ongoing recruitment procedure for a cohort study and comprised 336 men and women, aged 40 to 65 years. Exclusion criteria were elevated creatinine levels in blood, history of skin or atherosclerotic diseases, current use of vitamins or other supplements, and heavy smoking. Plasma tHcy, folate, vitamin B12, vitamin B6, creatinine, testosterone and estradiol, protein, and hematocrit were measured. Fat-free mass was assessed by skinfold thickness. The C677T polymorphism of the methylenetetrahydrofolate reductase (MTHFR), a key enzyme of folate and homocysteine metabolism, was determined by polymerase chain reaction (PCR) with restriction enzyme analysis. In this population, plasma tHcy ranged from 5 to 46 micromol/L. The frequency of the T allele of the MTHFR was 0.29, which is lower than in other populations. A total of 54.2% of this population was homozygote for the wild-type, 39.6% heterozygote, and 6.2% homozygote for the mutation. tHcy correlated negatively with folate and cobalamin concentration in blood and positively with creatinine. No correlation was seen with vitamin B6. From the gender-related variables, tHyc correlated significantly with fat-free mass and testosterone and inversely with estradiol. The difference between gender with regard to tHcy was mainly explained by differences in fat-free mass, but also by estradiol concentrations. The following contributions to the variation of tHcy were seen in a multivariate regression model: plasma cobalamin (11%), creatinine (11%), plasma folate (8%), fat-free mass (5%), estradiol (2%), MTHFR polymorphisms (2%), and plasma protein (1%). We concluded that tHcy in the general population has a variety of determinants ranging from nutrition, internal metabolic parameters to gender-related variables. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11398138     DOI: 10.1053/meta.2001.23286

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  16 in total

1.  Relationship between Homocysteine and Muscle Strength Decline: The Baltimore Longitudinal Study of Aging.

Authors:  Michelle L Vidoni; Kelley Pettee Gabriel; Sheng T Luo; Eleanor M Simonsick; R Sue Day
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-03-14       Impact factor: 6.053

2.  Hyperhomocysteinaemia is an independent risk factor for peripheral arterial disease in a Chinese Han population.

Authors:  Dan Rong; Jie Liu; Xin Jia; Daniah Al-Nafisee; Senhao Jia; Guoyi Sun; Yue Li; Weihang Lu; Haifeng Li; Hongpeng Zhang; Xiaohui Ma; Jiang Xiong; Xiaoping Liu; Raouf A Khalil; Wei Guo
Journal:  Atherosclerosis       Date:  2017-05-05       Impact factor: 5.162

3.  Plasma homocysteine, dietary B vitamins, betaine, and choline and risk of peripheral artery disease.

Authors:  Monica L Bertoia; Jennifer K Pai; John P Cooke; Michel M Joosten; Murray A Mittleman; Eric B Rimm; Kenneth J Mukamal
Journal:  Atherosclerosis       Date:  2014-04-28       Impact factor: 5.162

4.  Association of methylenetetrahydrofolate reductase (MTHFR-677 and MTHFR-1298) genetic polymorphisms with occlusive artery disease and deep venous thrombosis in Macedonians.

Authors:  Igor Spiroski; Sashko Kedev; Slobodan Antov; Todor Arsov; Marija Krstevska; Sloboda Dzhekova-Stojkova; Stojanka Kostovska; Dejan Trajkov; Aleksandar Petlichkovski; Ana Strezova; Olivija Efinska-Mladenovska; Mirko Spiroski
Journal:  Croat Med J       Date:  2008-02       Impact factor: 1.351

5.  Menopause modulates homocysteine levels in diabetic and non-diabetic women.

Authors:  G T Russo; A Di Benedetto; E Alessi; A Giandalia; A Gaudio; R Ientile; K V Horvath; B Asztalos; G Raimondo; D Cucinotta
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

6.  Elevated homocysteine levels are associated with low muscle strength and functional limitations in older persons.

Authors:  K M A Swart; N M van Schoor; M W Heymans; L A Schaap; M den Heijer; P Lips
Journal:  J Nutr Health Aging       Date:  2013       Impact factor: 4.075

7.  Association between Elevated Plasma Homocysteine and Low Skeletal Muscle Mass in Asymptomatic Adults.

Authors:  Jae-Hyeong Choi; Jin-Woo Seo; Mi-Yeon Lee; Yong-Taek Lee; Kyung Jae Yoon; Chul-Hyun Park
Journal:  Endocrinol Metab (Seoul)       Date:  2022-02-08

8.  Epidemiology of 40 blood biomarkers of one-carbon metabolism, vitamin status, inflammation, and renal and endothelial function among cancer-free older adults.

Authors:  Hana Zahed; Mattias Johansson; Per M Ueland; Øivind Midttun; Roger L Milne; Graham G Giles; Jonas Manjer; Malte Sandsveden; Arnulf Langhammer; Elin Pettersen Sørgjerd; Kjell Grankvist; Mikael Johansson; Neal D Freedman; Wen-Yi Huang; Chu Chen; Ross Prentice; Victoria L Stevens; Ying Wang; Loic Le Marchand; Lynne R Wilkens; Stephanie J Weinstein; Demetrius Albanes; Qiuyin Cai; William J Blot; Alan A Arslan; Anne Zeleniuch-Jacquotte; Xiao-Ou Shu; Wei Zheng; Jian-Min Yuan; Woon-Puay Koh; Kala Visvanathan; Howard D Sesso; Xuehong Zhang; J Michael Gaziano; Anouar Fanidi; David Muller; Paul Brennan; Florence Guida; Hilary A Robbins
Journal:  Sci Rep       Date:  2021-07-05       Impact factor: 4.996

Review 9.  Fenofibrate-induced hyperhomocysteinaemia: clinical implications and management.

Authors:  Jutta Dierkes; Sabine Westphal; Claus Luley
Journal:  Drug Saf       Date:  2003       Impact factor: 5.228

Review 10.  Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels.

Authors:  Jutta Dierkes; Claus Luley; Sabine Westphal
Journal:  Vasc Health Risk Manag       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.